Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Soufflé Therapeutics, Inc. has closed an oversubscribed $135 million Series B financing led by Juvia Group to advance its lead clinical programs and continued pipeline progress.
Amount Raised
$135 Million
Round Type
Series B
Investors
Description
Soufflé Therapeutics, Inc. announced the close of an oversubscribed $135 million Series B financing. The funding will support the advancement of its lead clinical programs and continued progress on its pipeline. The round saw participation from several leading institutional investors
Fundz sees it the moment Soufflé Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSoufflé Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.